mofezolac has been researched along with Bone Loss, Osteoclastic in 1 studies
mofezolac: Cyclooxygenase 1 inhibitor; structure in first source; RN from Toxlit
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawashima, M | 1 |
| Fujikawa, Y | 1 |
| Itonaga, I | 1 |
| Takita, C | 1 |
| Tsumura, H | 1 |
1 other study available for mofezolac and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
The effect of selective cyclooxygenase-2 inhibitor on human osteoclast precursors to influence osteoclastogenesis in vitro.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bone Resorption; Celecoxib; Cell Growth Processes; Cell Sur | 2009 |